Introduction: The Clinical Paradox of Post-PCI Troponin Leaks
In the modern era of interventional cardiology, percutaneous coronary intervention (PCI) has reached unprecedented levels of safety and efficacy. However, the phenomenon of post-procedural troponin increase (pTI) remains a common occurrence, even in elective cases involving stable coronary artery disease. While often asymptomatic, these elevations in cardiac biomarkers are not benign; they are frequently associated with an increased risk of long-term mortality and major adverse cardiovascular events (MACE). The challenge for clinicians has been twofold: identifying which patients are at highest risk and determining which definition of periprocedural myocardial infarction (PMI) carries the most clinical weight. A recent large-scale retrospective analysis from Mount Sinai Hospital provides critical insights into these predictors, offering a blueprint for more individualized patient care.
Highlights
1. Post-procedural troponin increase (pTI) occurred in 16.3% of patients when using the Fourth Universal Definition of Myocardial Infarction (UDMI) criteria, but only in 4.4% when applying the more stringent Academic Research Consortium 2 (ARC-2) criteria.
2. Modifiable and non-modifiable factors, including LDL cholesterol levels, lesion length, and stent diameter, were identified as significant predictors across both definitions.
3. The routine use of intravascular imaging (IVI) and a history of prior PCI were found to have significant protective effects against the development of pTI.
Background: Defining Periprocedural Myocardial Injury
Periprocedural myocardial injury is a recognized complication of PCI, resulting from various mechanisms such as side-branch occlusion, distal embolization of plaque debris, slow-flow or no-reflow phenomena, and direct vessel wall trauma. Historically, the medical community has debated the threshold at which troponin elevation becomes clinically significant. The Fourth Universal Definition of Myocardial Infarction (UDMI) sets a relatively low bar (≥5× upper reference limit), whereas the Academic Research Consortium 2 (ARC-2) proposes a higher threshold (≥35× URL) to identify events more likely to impact hard clinical outcomes. Understanding the specific predictors for each threshold is essential for procedural planning and post-procedural management.
Study Design and Methodology
This study was a retrospective analysis of 10,592 consecutive patients who underwent elective PCI with drug-eluting stent (DES) implantation at Mount Sinai Hospital, New York, between 2012 and 2022. To ensure the integrity of the data, patients with elevated baseline troponin (indicating an ongoing acute coronary syndrome or other myocardial injury) and those with missing troponin values were excluded. The primary objective was to identify independent predictors of pTI according to both the UDMI (≥5× URL) and ARC-2 (≥35× URL) definitions. The researchers utilized multivariable logistic regression with stepwise selection to isolate candidate covariates, including clinical demographics, laboratory values, and complex angiographic features.
Key Findings: Defining the Predictors of pTI
Incidence and Threshold Discrepancy
The study revealed a stark difference in pTI incidence based on the definition used. Nearly one in six patients (16.3%) met the UDMI criteria, highlighting how common minor myocardial injury is during elective procedures. Conversely, the ARC-2 criteria were met by only 4.4% of the cohort, suggesting that severe periprocedural injury is relatively rare in the contemporary DES era.
Shared Predictors Across Definitions
Several factors were consistently associated with pTI regardless of the threshold used. Elevated low-density lipoprotein cholesterol (LDL-C) emerged as a significant predictor, likely reflecting a higher burden of unstable or lipid-rich plaque prone to distal embolization. Procedural factors, specifically increased lesion length and larger maximum stent diameters, also predicted pTI. These findings suggest that higher-volume plaque modification and more extensive vessel wall interaction inherently increase the risk of myocardial injury.
The Protective Power of Imaging and Experience
One of the most clinically actionable findings was the protective effect of intravascular imaging (IVI). The use of IVUS or OCT was associated with a lower risk of pTI, likely because these tools allow for better lesion preparation, more accurate stent sizing, and the early detection of complications like edge dissections or malapposition. Additionally, patients with a history of prior PCI and those with a higher left ventricular ejection fraction (LVEF) showed lower rates of pTI, potentially indicating a degree of ischemic preconditioning or better physiological reserve.
Definition-Specific Predictors
The study identified unique predictors for the two definitions. For the more sensitive UDMI definition, female sex, anemia, and the use of a P2Y12 inhibitor loading dose (as opposed to being on chronic maintenance therapy) were predictive of pTI. In contrast, chronic kidney disease (CKD) was a specific predictor only for the more severe ARC-2-defined pTI, highlighting the vulnerability of the renal-impaired population to major periprocedural insults.
Expert Commentary: Mechanistic Insights and Clinical Application
The discrepancy between UDMI and ARC-2 predictors is biologically plausible. Minor troponin leaks (UDMI) may be driven by patient-specific factors like anemia (which limits oxygen delivery) or acute loading of antiplatelet agents (which may not have reached peak therapeutic effect during the procedure). However, major troponin elevations (ARC-2) are more likely driven by systemic fragility, such as CKD, which is associated with calcified, complex lesions and a higher inflammatory milieu.
The protective role of intravascular imaging cannot be overstated. As we move toward more complex PCI in stable patients, the ‘eyes’ provided by IVUS and OCT are essential to minimize distal embolization and ensure optimal stent expansion. Furthermore, the association between LDL-C and pTI reinforces the importance of aggressive statin therapy prior to elective intervention to ‘stabilize’ plaque morphology.
However, the study is not without limitations. Being a single-center retrospective analysis, there may be inherent biases in procedural techniques or patient selection. Additionally, while pTI is a known marker of mortality, this specific study focused on predictors rather than long-term outcomes, though the link is well-established in existing literature.
Conclusion and Summary
The Mount Sinai analysis underscores that post-procedural troponin increase is not a random event but a predictable outcome driven by a mix of clinical and angiographic variables. By identifying high-risk profiles—such as patients with long lesions, high LDL-C, or CKD—interventionalists can tailor their procedural strategy. The routine integration of intravascular imaging and the optimization of medical therapy before the patient reaches the cath lab are the most effective strategies to mitigate this risk. Ultimately, these findings support a more nuanced, individualized approach to risk assessment in elective PCI, ensuring that the benefits of revascularization are not undermined by avoidable periprocedural injury.
References
1. Gilhooley S, Gitto M, Spirito A, et al. Predictors of postprocedural troponin increase in patients undergoing elective percutaneous coronary intervention. Heart. 2025;112(2):111-113. doi:10.1136/heartjnl-2025-325990.
2. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264.
3. Garcia-Garcia HM, McFadden EP, Farb A, et al. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document. Circulation. 2018;137(24):2635-2650.
